Open AccessClinical profile of woman’s cancer-associated diabetes mellitus patients in Dr. Kariadi hospital Semarang
Author(s) -
Kartika Widyakusuma Agung Putri,
Heri Nugroho Hario Seno,
Ika Vemilia Warlisti,
Dwi Lestari Partiningrum,
Ratnasari Dwi Cahyanti
Publication year - 2022
Publication title -
international journal of health sciences (ijhs) (en línea)
Language(s) - English
Resource type - Journals
eISSN - 2550-6978
pISSN - 2550-696X
DOI - 10.53730/ijhs.v6ns3.5341
Subject(s) - medicine , diabetes mellitus , cancer , breast cancer , epidemiology , ovarian cancer , glycemic , gynecology , medical record , risk factor , obstetrics , pediatrics , endocrinology
Background: Diabetes and womans cancers are chronic diseases, which are multifactorial, and its prevalence increases every years. Several epidemiological studies have shown that diabetes is the risk factor for severals cancers, including gynecologic and breast cancer. Aim: To determine the prevalence and clinical profile of DM-cancer patients who were hospitalized in Dr. Kariadi Hospital Semarang from January 2016 – May 2017. Methods: A descriptive study using medical reports obtained from Dr. Kariadi Semarang Hospital from January 2016 – May 2017. Result: The prevalence of DM-womans cancer in Dr Kariadi Semarang Hospital in January 2016-May 2017 was 87 cases (7.1%). The highest prevalence was vulvar cancer (14.3%). The majority of patients were in stage II and III (77.3%). The diagnosis of DM in most patients was made before the diagnosis of cancer (62.1%). The age when the DM was first diagnosed was mostly over 40 years (97%). The majority of cancer-DM patients did not have therapy routinely (39.4%) and have poor glycemic control (47%). The most used DM therapy was combination therapy (28.8%). Risk factors for cancer in DM-cancer patients were age ≥50 years (80.3%), excess BMI (51.5%) and use of hormonal contraceptives (45.4%).